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We have read with interest the respectfully written correspondence by Wüthrich et al. regarding 
antimicrobial silk textiles for atopic dermatitis (AD) (1). Though it was submitted as a comment to 
the European consensus-based S2k guidelines on treatment of atopic eczema (2,3), it is discussing in 
70% of its length the CLOTHES trial – published in two non-JEADV-publications which we have 
neither designed nor authored (4,5).  
 
Wüthrich et al. have correctly realized that, based on current evidence, the S2k guidelines author 
group has not issued a recommendation for or against silk clothing anymore (3), whereas the ETFAD 
position paper published 2016 still does (6). Silver coated textiles are still recommended in Fig. 1 of 
the European consensus-based S2k guidelines in mild, moderate and severe AD for both adults and 
children (2,3). Newer evidence on the durability of silver coated antibacterial garments, which has 
been published after the March 2017 inclusion deadline of the guidelines, indicates a deliverable 
antimicrobial activity of silver coated functional textiles (7). The extensive, several decades long, 
positive clinical experience of the correspondence authors is well noted, and corresponds to their 
published experience of one week treatment in 14 AD children (8). Both have not been cited in the 
respective part of the S2k guidelines (3). The next version of our consenus-based guidelines may 
incorporate additional data. 
 
We feel that the majority of the correspondence authors’ comments should have been filed long ago 
to the authors of the CLOTHES trial in the respective journals, but we will nevertheless try to address 
these based on published knowledge and what seems feasible in a short response: 
 
a) The CLOTHES trial was designed as a pragmatic trial mimicking real life conditions and included 
300 children. Even if the garments should be worn as much as possible, the minimal compliance 
requirement of participants makes sense to be as low as clinical reality. 
 
b) In our opinion, the therapeutic decision for long-term antibacterial intervention should include a 
long-term estimation of disease severity. The NESS has probably been chosen as one of the inclusion 
criteria for the CLOTHES trial, because it is a validated epidemiological tool for assessing eczema 
severity over the last 12 months, and not just the current objective signs of AD. In addition, there 
had to be lesions that could be treated and assessed.  
 
c) A different trial with different inclusion criteria might have shown different results. This may or 
may not be proven by conducting a new trial, and we would like to include the results in the next 
version of the guidelines. 
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4) For all other methodological aspects of the CLOTHES trial, we suggest writing a correspondence to 
PloS Med so that these aspects may receive the attention which they deserve, as well as an accurate 
reply by the CLOTHES trial authors.  
 
In conclusion, the field of functional textiles is interesting and fast moving, and the section authors, 
as well as the entire guidelines group will happily include additional evidence in the next version of 
the guidelines. 
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